Rx Rundown: Novartis, Goldman Sachs, Klick Health and more
Check out this week’s medical marketing news, people on the move and industry chatter.
Stay updated with breaking news from Michael Streit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Check out this week’s medical marketing news, people on the move and industry chatter.
In past articles, we have examined a motion under CPLR § 3213... CPLR § 3213 is a procedural mechanism that allows a party to make a motion for summary judgment before filing a...
Several inches of rain fell across western Massachusetts Friday, and all this rain is causing nightmares for some homeowners.
A clinical trial is underway for STX-478, a potential new treatment for breast cancer and other tumors, with initial results expected later this year.
Scorpion Therapeutics, a clinical-stage oncology company, has announced that the first patient has been dosed in a phase 1/2 clinical trial of STX-478, its treatment for breast cancer and other solid tumors.